Behrens, C K <br/><br/>
CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout mice.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Mar 2001 
 - 3240-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.166.5.3240  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>COS Cells<br/>Cell Division--genetics<br/>Chemotactic Factors--physiology<br/>Fas Ligand Protein<br/>Graft Rejection--genetics<br/>H-2 Antigens--genetics<br/>Leukemia L1210--genetics<br/>Ligands<br/>Membrane Glycoproteins--biosynthesis<br/>Mice<br/>Mice, Inbred DBA<br/>Mice, Knockout<br/>Mice, Nude<br/>Mice, Transgenic<br/>Neoplasm Transplantation<br/>Oligonucleotides, Antisense--genetics<br/>Perforin<br/>Pore Forming Cytotoxic Proteins<br/>Receptors, Antigen, T-Cell--genetics<br/>Serpins--genetics<br/>Solubility<br/>Transfection<br/>Transgenes--immunology<br/>Viral Proteins<br/>fas Receptor--genetics